Curetis NV (CURE):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Curetis NV (CURE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7358
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue infections, and pneumonia; and also used in the laboratory for multiplex polymerase chain reaction pcr diagnostics. Curetis serves medical, healthcare companies, biotechnology, contract research and pharmaceutical companies, among others. The company sells its products through a network of distributors located across Germany. It has its operations in in France, Switzerland, Netherlands, the UK, the US and Germany. Curetis is headquartered in Stuttgart, Germany.

Curetis NV (CURE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Curetis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Curetis NV, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Curetis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Curetis NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Curetis NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Curetis NV, Medical Equipment, Deal Details 12
Asset Purchase 12
Curetis to Acquire qPCR Platform from Carpegen and Systec 12
Curetis to Acquire Assets from Siemens Technology Accelerator 14
Venture Financing 15
Curetis Raises USD18 Million in Extended Series B Venture Financing 15
Curetis Raises US$16.3 Million In Series B Financing 17
Partnerships 19
Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 19
Curetis Enters Into Licensing Agreement With Cempra For Unyvero 20
Curetis Enters into Agreement with MGI Tech 21
Curetis to Enter into Agreement with MGI Tech 22
Acumen Research Labs Enters into Distribution Agreement with Curetis 23
Curetis Enters into Distribution Agreement with Arrow Diagnostics 24
Curetis And Laboratorios LETI Enter Into Distribution Agreement For Unyvero In Spain And Portugal 25
Curetis Enters Into Distribution Agreement With Elitech 26
Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero 27
Curetis Enters Into Distribution Agreement With Advanced Technology For Unyvero Solution 28
Equity Offering 29
Curetis to Raise USD4.9 Million in Private Placement of Shares 29
Curetis Plans to Raise USD10 Million in Private Placement of Shares 30
Curetis Raises USD44 Million in IPO 31
Debt Offering 32
Curetis to Raise up to USD23.2 Million in Private Placement of Notes 32
Curetis NV – Key Competitors 33
Curetis NV – Key Employees 34
Curetis NV – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Strategy And Business Planning 36
Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing 36
Financial Announcements 37
Aug 14, 2018: Curetis announces financial results for the first six months of 2018 37
May 18, 2018: Curetis Publishes Business and Financial Update for the First Quarter 2018 40
Apr 30, 2018: Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018 42
Nov 15, 2017: Curetis Publishes Business and Financial Update for the First Nine Months of 2017 45
Aug 16, 2017: Curetis Announces Financial Results for the First Six Months of 2017 47
May 24, 2017: Curetis Provides Business and Financial Update for the First Quarter 2017 50
Apr 12, 2017: Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance 52
Corporate Communications 54
Aug 14, 2018: Curetis announces change in Curetis USA management 54
Mar 06, 2018: Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley 55
Aug 16, 2017: Curetis Announces Management Board Changes 56
Jun 23, 2017: Curetis Reports Results of the Annual Shareholder Meeting Held on June 23, 2017 57
Apr 12, 2017: Curetis Expands Supervisory and Medical Advisory Boards 58
Product News 59
Mar 14, 2018: Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology 59
Other Significant Developments 60
Feb 05, 2018: Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Curetis NV, Medical Equipment, Key Facts, 2017 2
Curetis NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Curetis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Curetis NV, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Curetis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Curetis NV, Deals By Market, 2012 to YTD 2018 9
Curetis NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Curetis to Acquire qPCR Platform from Carpegen and Systec 12
Curetis to Acquire Assets from Siemens Technology Accelerator 14
Curetis Raises USD18 Million in Extended Series B Venture Financing 15
Curetis Raises US$16.3 Million In Series B Financing 17
Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 19
Curetis Enters Into Licensing Agreement With Cempra For Unyvero 20
Curetis Enters into Agreement with MGI Tech 21
Curetis to Enter into Agreement with MGI Tech 22
Acumen Research Labs Enters into Distribution Agreement with Curetis 23
Curetis Enters into Distribution Agreement with Arrow Diagnostics 24
Curetis And Laboratorios LETI Enter Into Distribution Agreement For Unyvero In Spain And Portugal 25
Curetis Enters Into Distribution Agreement With Elitech 26
Curetis Enters Into Co-Development Agreement With Heraeus Medical For Unyvero 27
Curetis Enters Into Distribution Agreement With Advanced Technology For Unyvero Solution 28
Curetis to Raise USD4.9 Million in Private Placement of Shares 29
Curetis Plans to Raise USD10 Million in Private Placement of Shares 30
Curetis Raises USD44 Million in IPO 31
Curetis to Raise up to USD23.2 Million in Private Placement of Notes 32
Curetis NV, Key Competitors 33
Curetis NV, Key Employees 34
Curetis NV, Other Locations 35
Curetis NV, Subsidiaries 35

List of Figures
Curetis NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Curetis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Curetis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Curetis NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Curetis NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Curetis NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Curetis NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Curetis NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Curetis NV (CURE):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boardriders, Inc:企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Mapletree Industrial Trust Management Ltd.:企業の戦略・SWOT・財務情報
    Mapletree Industrial Trust Management Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mapletree Industrial Trust Management Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. …
  • Ocado Group Plc:企業の戦略・SWOT・財務情報
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Shionogi & Co., Ltd.:企業のM&A・事業提携・投資動向
    Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • McDermott International Inc (MDR):電力:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …
  • MYOS RENS Technology Inc (MYOS):製薬・医療:M&Aディール及び事業提携情報
    Summary MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken …
  • Hitachi Capital (UK) PLC:企業の戦略・SWOT・財務情報
    Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report Summary Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Centrais Eletricas de Santa Catarina SA (CLSC4):企業の財務・戦略的SWOT分析
    Centrais Eletricas de Santa Catarina SA (CLSC4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Telos Corporation:企業の戦略・SWOT・財務情報
    Telos Corporation - Strategy, SWOT and Corporate Finance Report Summary Telos Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Electricity Generating Authority of Thailand:発電所・企業SWOT分析
    Electricity Generating Authority of Thailand - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Panmure Gordon & Co Limited (PMR):企業の財務・戦略的SWOT分析
    Panmure Gordon & Co Limited (PMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. The company manufactures and markets high performance polymers and specialty chemicals. Its products include bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Renata Ltd (RENATA):企業の財務・戦略的SWOT分析
    Summary Renata Ltd (Renata), formerly Pfizer Bangladesh Ltd, is a pharmaceutical and animal health product company. Its pharmaceutical product portfolio comprises amino acid supplement, anti viral preparation, anti allergic preparations, anti asthmatic preparation, anti bacterial preparations, among …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆